KEENE, N.H. -- (BUSINESS WIRE) -- G2 Intelligence — a 30+ year leader in research, reporting, and analysis on the business of the diagnostic laboratory industry — announces the release of Advanced Blood Management: Generate Significant Savings While Improving Patient Outcomes. This all-new study provides an unprecedented look at the value that restrictive protocols can bring to both the financial and the population health of hospitals and health institutions that utilize blood products for all types of patient care (e.g., cardiac surgery, critical care, etc.).
“Recent evidence has shown that transfusions raise the rates of a number of serious complications, among them circulatory overload, acute lung injury and respiratory failure, and sepsis,” according to Associate Director of G2 Intelligence’s Advisory Services, and the report’s lead analyst, Jennifer Musumeci, MS. “We found that ample opportunity exists for organizations to reduce blood utilization, cut adverse events, decrease length of stay, and provide cost savings — by embracing the new value-based paradigm and employing smarter blood management protocols.”
The research includes a wealth of actionable, must-have intelligence, including:
“This is, quite simply, the ultimate resource for health institutions that utilize blood products,” adds L. Eleanor Herriman, M.D., MBA, contributing analyst and Managing Director of G2 Intelligence Advisory Services. “Everyone from hospital administrators, quality, safety officers, medical directors and blood bank leadership can benefit from the succinct, accessible data in this unique report.”
If you would like to know more about multi-user/multi-location pricing, please contact Jonathan Wentworth-Ping, Director of Sales at jping@G2Intelligence.com or by phone at 1-603-357-8160.
About G2 Intelligence
Advancing the Business of Diagnostic Medicine
G2 Intelligence provides timely, accurate, and trusted analysis of industry and market trends, legal and regulatory developments, and technology and innovation that directly affect the operations, financial performance, and competitive position of diagnostic testing laboratories and related medical services providers.
G2 Intelligence has covered and reported on the diagnostic industry for over 30 years. Today, the company delivers topical and analytical periodicals, proprietary research studies, and custom advisory services, and through live and virtual events, facilitates industry meetings and information exchanges.
G2 Intelligence is a division of Kennedy Information, LLC, a leading provider of professional markets analysis. Kennedy’s parent company, Bloomberg BNA, a wholly owned subsidiary of Bloomberg, is a leading source of legal, regulatory, and business information for professionals. Its network of more than 2,500 reporters, correspondents, and leading practitioners delivers expert analysis, news, practice tools, and guidance — the information that matters most to professionals.
More information is available for you at www.G2Intelligence.com.